(Q41313856)

29 September 2017

1 reference

title

Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors (English)

1 reference

29 September 2017

1 reference

1 reference

Sershen H

1

1 reference

29 September 2017

Hashim A

series ordinal

2

1 reference

29 September 2017

Lajtha A

series ordinal

3

1 reference

29 September 2017

publication date

1 January 1997

1 reference

29 September 2017

published in

Brain Research Bulletin

1 reference

29 September 2017

volume

42

1 reference

29 September 2017

issue

3

1 reference

29 September 2017

page(s)

161-168

1 reference

Serotonergic mechanisms of cocaine effects in humans.

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Dopamine releasing effect of phenylbiguanide in rat striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Ion channel inhibitors may function as potential modulators of cocaine binding

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Antagonism by citalopram and tianeptine of presynaptic 5-HT1B heteroreceptors inhibiting acetylcholine release

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Effect of chronic antidepressant treatment on 5-HT1B presynaptic heteroreceptors inhibiting acetylcholine release

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Inhibitory effects of ibogaine on cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Conditioned cocaine induced hyperactivity: an association with increased medial prefrontal cortex serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

High affinity ibogaine binding to a mu opioid agonist site

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Comparative study of the effects of mu, delta and kappa opioid agonists on 3H-dopamine uptake in rat striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Effects of ibogaine on naloxone‐precipitated withdrawal in morphine‐dependent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Effects and aftereffects of ibogaine on morphine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with D-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Opioid receptor-mediated inhibition of 3H-dopamine and 14C-acetylcholine release from rat nucleus accumbens slices. A study on the possible involvement of K+ channels and adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Monoamine systems in the discriminative effects of spiradoline, a kappa-opioid agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Ibogaine possesses a selective affinity for σ2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Interaction of ibogaine and d-amphetamine: in vivo microdialysis and motor behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Psycotherapeutic Possibilities of New Fantasy-Enhancing Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Flunarizine potentiates cocaine-induced dopamine release and motor stimulation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Radioligand-binding study of noribogaine, a likely metabolite of ibogaine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Tryptophan depletion and attenuation of cue-induced craving for cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Serotonergic mediation of cocaine seizures in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Ibogaine antagonizes cocaine-induced locomotor stimulation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Ibogaine reduces preference for cocaine consumption in C57BL/6By mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

The effect of ibogaine on kappa-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6By mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

The effect of ibogaine on Sigma- and NMDA-receptor-mediated release of [3H]dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Effect of ibogaine on cocaine-induced efflux of [3H] dopamine and [3H] serotonin from mouse striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

A preliminary investigation of ibogaine: case reports and recommendations for further study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

Cerebral Pharmacokinetics of Tremor-Producing Harmala and Iboga Alkaloids

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900296-1

7 January 2021

10.1016/S0361-9230(96)00296-1

Identifiers

DOI

1 reference

29 September 2017

1 reference